Sage Therapeutics, Inc. (SAGE) Social Stream



Sage Therapeutics, Inc. (SAGE): $12.95

0.06 (+0.47%)

POWR Rating

Component Grades

Momentum

D

Stability

F

Sentiment

Quality

C

Add SAGE to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#178 of 360

in industry

SAGE THERAPEUTICS INC (SAGE) Price Targets From Analysts

Use the tables below to see what analysts covering SAGE THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-12-01 20 $105 $48 $73.368 $26.37 178.23%
2021-12-20 19 $105 $48 $72.842 $26.37 176.23%
2022-01-12 19 $105 $48 $73.157 $26.37 177.43%
2022-01-26 17 $105 $48 $73.157 $26.37 177.43%
2022-02-16 18 $105 $48 $72.315 $26.37 174.23%
2022-02-25 18 $105 $48 $71.736 $26.37 172.04%
2022-02-28 17 $105 $48 $70.055 $26.37 165.66%
2022-03-21 17 $105 $40 $68.722 $26.37 160.61%
2022-04-01 18 $105 $37 $67.052 $26.37 154.27%
2022-05-03 18 $105 $37 $67.21 $26.37 154.87%
2022-05-04 18 $105 $37 $65.7 $26.37 149.15%
2022-05-06 18 $105 $37 $64.631 $26.37 145.09%
2022-05-10 18 $105 $37 $64.421 $26.37 144.3%
2022-05-24 19 $105 $37 $64.85 $26.37 145.92%
2022-06-01 19 $105 $37 $65 $26.37 146.49%
2022-06-13 18 $105 $36 $63.5 $26.37 140.8%
2022-07-21 18 $105 $36 $61 $26.37 131.32%
2022-08-03 18 $105 $36 $57.941 $26.37 119.72%
2022-08-04 18 $105 $36 $59.611 $26.37 126.06%
2022-09-19 18 $105 $36 $59.5 $26.37 125.64%
2022-10-17 16 $105 $36 $59.5 $26.37 125.64%
2022-11-01 14 $105 $36 $59.111 $26.37 124.16%
2022-11-08 17 $105 $36 $59.111 $26.37 124.16%
2022-11-11 18 $105 $36 $57 $26.37 116.15%
2022-11-21 20 $105 $36 $56.85 $26.37 115.59%
2022-12-07 20 $105 $36 $55 $26.37 108.57%
2023-02-06 20 $105 $36 $55.3 $26.37 109.71%
2023-02-17 20 $105 $36 $55.5 $26.37 110.47%
2023-02-21 21 $105 $36 $56.05 $26.37 112.55%
2023-03-10 21 $105 $36 $56.1 $26.37 112.74%
2023-03-13 22 $105 $36 $56.285 $26.37 113.44%
2023-05-03 22 $105 $36 $57.65 $26.37 118.62%
2023-05-04 22 $105 $40 $57.8 $26.37 119.19%
2023-05-09 22 $105 $40 $56.894 $26.37 115.75%
2023-05-22 22 $105 $40 $57.75 $26.37 119%
2023-06-15 21 $105 $40 $57.473 $26.37 117.95%
2023-07-09 21 $105 $40 $57.21 $26.37 116.95%
2023-07-23 20 $105 $40 $58.166 $26.37 120.58%
2023-08-02 20 $105 $37 $57.777 $26.37 119.1%
2023-08-07 20 $105 $37 $56.611 $26.37 114.68%
2023-08-08 22 $105 $18 $36.7 $26.37 39.17%
2023-08-09 21 $79 $18 $33.578 $26.37 27.33%
2023-08-22 22 $79 $18 $31.631 $26.37 19.95%
2023-09-01 22 $79 $18 $31.736 $26.37 20.35%
2023-09-05 22 $79 $18 $31.3 $26.37 18.7%
2023-10-08 23 $79 $18 $30.571 $26.37 15.93%
2023-10-13 23 $79 $18 $30.714 $26.37 16.47%
2023-11-07 22 $79 $18 $30.2 $26.37 14.52%
2023-11-09 22 $79 $18 $30.15 $26.37 14.33%
2023-11-29 22 $79 $18 $26.944 $26.37 2.18%
2023-12-15 22 $79 $18 $25.388 $26.37 -3.72%
2023-12-18 22 $79 $18 $25.388 $26.37 -3.72%
2023-12-29 22 $79 $18 $25.277 $26.37 -4.14%

The Trend in the Analyst Price Target


SAGE's average price target has moved down $32.42 over the prior 33 weeks.

Over the past 49 weeks, SAGE's average upside potential has been 46.1%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-13 21 105 36 56.285 43.36 29.81%
2023-08-09 21 79 18 33.578 18.99 76.82%
2023-11-07 22 79 18 30.200 19.63 53.85%
2023-11-29 22 79 18 26.944 19.48 38.32%
2023-12-26 22 79 18 25.277 22.17 14.01%

SAGE Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.64 4 0 18 0 0 22

The Trend in the Broker Recommendations


SAGE's average broker recommendation rating worsened by 1.09 over the prior 45 months.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • SAGE THERAPEUTICS INC's variance in analysts' estimates is lower than -6500.5% of all US stocks.
  • In the context of stocks in the mid market cap category, SAGE THERAPEUTICS INC's number of analysts covering the stock is higher than 7110.21% of them.
  • In terms of how SAGE THERAPEUTICS INC fares relative to stocks in the mid market cap category, note that its upside potential (average analyst target price relative to current price) is higher than 5308.24% of that group.
  • In terms of how SAGE THERAPEUTICS INC fares relative to Pharmaceutical Products stocks, note that its average analyst price target is greater than 5084.53% of that group.

Stocks similar to SAGE THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are AMPH, FGEN, and TARO.

Make investment decisions regarding SAGE using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!